STOCK TITAN

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Emergent BioSolutions (NYSE:EBS) announced its upcoming participation in two major investor conferences. The company will present at the Wells Fargo 20th Annual Healthcare Conference on September 4, 2025, at 3:00 PM ET, and at the HCW 27th Annual Global Investment Conference on September 9, 2025, at 1:30 PM ET.

Senior management will be available for one-on-one meetings at both events. Investors can access the presentations and replays through the Investors section of Emergent's website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

-1.38%
1 alert
-1.38% News Effect

On the day this news was published, EBS declined 1.38%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:

  • Wells Fargo 20th Annual Healthcare Conference
    September 4, 2025
    3:00 pm ET
    Webcast link here
    One-on-one meetings
  • HCW 27th Annual Global Investment Conference
    September 9, 2025
    1:30 PM ET
    Webcast link here
    One-on-one meetings

Please contact your conference representative to request one-on-one meetings.

Participants can view the presentations and replays by visiting the Investors page of Emergent’s website.

About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threat, visit our website and follow us on LinkedInXInstagramApple Podcasts and Spotify.

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com  

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com


FAQ

When is Emergent BioSolutions (EBS) presenting at the Wells Fargo Healthcare Conference 2025?

Emergent BioSolutions will present at the Wells Fargo Healthcare Conference on September 4, 2025 at 3:00 PM ET.

When is EBS presenting at the HCW Global Investment Conference 2025?

EBS will present at the HCW Global Investment Conference on September 9, 2025 at 1:30 PM ET.

How can investors access Emergent BioSolutions' conference presentations?

Investors can access the presentations and replays through the Investors page of Emergent's website.

Will Emergent BioSolutions offer one-on-one meetings at these conferences?

Yes, one-on-one meetings are available at both conferences. Interested parties should contact their conference representatives to schedule meetings.
Emergent Biosolutions Inc

NYSE:EBS

EBS Rankings

EBS Latest News

EBS Latest SEC Filings

EBS Stock Data

627.61M
50.96M
2.84%
70.19%
16.33%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
GAITHERSBURG